Third-Trimester NT-proBNP for Pre-eclampsia Risk Prediction
Unselected NT-proBNP screening in the early third trimester has limited clinical value for predicting short- or long-term pre-eclampsia risk when compared to angiogenic biomarkers.
Authors
- Diana Lindner (ORCID: https://orcid.org/0000-0001-5477-769X)
- Birgitte Møller Luef (ORCID: https://orcid.org/0000-0002-8356-5925)
- Dorte Glintborg (ORCID: https://orcid.org/0000-0002-8338-8025)
- Marianne Andersen (ORCID: https://orcid.org/0000-0002-4603-9504)
- Tanja Zeller (ORCID: https://orcid.org/0000-0003-3379-2641)
- Dirk Westermann (ORCID: https://orcid.org/0000-0002-7542-1956)
- Lucas Bacmeister (ORCID: https://orcid.org/0000-0001-8240-2270)
- Till Keller (ORCID: https://orcid.org/0000-0002-0895-6491)
- Anna Birukov (ORCID: https://orcid.org/0000-0002-8306-3351)
- Ralf Dechend (ORCID: https://orcid.org/0000-0001-6636-3080)
- Adrian Heidenreich (ORCID: https://orcid.org/0000-0003-0756-6755)
- Annette Buellesbach (ORCID: https://orcid.org/0009-0009-3632-0042)
- Jan Stener Jørgensen (ORCID: https://orcid.org/0000-0003-3084-3116)
- Kristin Kräker (ORCID: https://orcid.org/0000-0002-4032-5382)
Institutions
- Harvard University (US)
- Universität Hamburg (DE)
- University of Southern Denmark (DK)
- Max Delbrück Center (DE)
- University Medical Center Freiburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Schleswig-Holstein (DE)
- German Centre for Cardiovascular Research (DE)
- Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101671
- Citations
- 4
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 8.23